Third party manufacturing for clinical samples allowed

Effective from Feb. next year the third party manufacturing for clinical samples seems to be granted.

Any new drug in clinical trials can be administered under the KFDA's prior approval far before its commercialization, especially for the patients suffering from life threatening diseases in view of humanitarian points after adopting so called Treatment IND (Investigational New Drug) effecti...